Stichting Het Nederlands Kanker Instituut

Amsterdam, North Holland 1066 CX

1 studies enrolling now · 1 studies all time

What they study most

ALK-positive Non-small Cell Lung Cancer (NSCLC), Non Small Cell Lung Cancer

Studies at this site

• Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors — Available (expanded access)